Metformin monotherapy in melanoma: a pilot, open‐label, prospective, and multicentric study indicates no benefit

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles